We previously have shown that hypoxia increases the expression of P-glycoprotein, which in turn increases tumor cell capacity to actively extrude chemotherapeutic agents and may contribute to tumor drug resistance. This event is mediated through the hypoxia-inducible factor (HIF-1). Here, we investigated the role of the stress-activated protein kinase c-Jun NH 2 -terminal kinase (JNK) in the signaling mechanisms underlying these events. Hypoxia activates JNK activity in vitro and in vivo. Overexpression of mitogen-activated protein kinase (MAPK) kinase kinase (MEKK-1), which preferentially activates JNK, mimics, in a nonadditive way, hypoxia-induced activity of the MDR1 promoter and expression of MDR1 mRNA and P-glycoprotein. Furthermore, the JNK inhibitor SP600125 selectively and specifically inhibits hypoxia-and MEKK-1-induced MDR1 promoter activity in a dose-dependent manner. JNK inhibition also reversed hypoxia-and MEKK-1-induced activity of an HIF-1-dependent reporter gene. MEKK-1-induced MDR1 expression depends on a functional HIF-1 binding site (hypoxia-responsive element). Hypoxiabut not cobalt chloride-dependent HIF-1-DNA binding and transcriptional activation was inhibited by SP600125, indicating that hypoxiainduced signaling to HIF-1 depends on JNK activation. Because it has been reported that reactive oxygen species are increased in hypoxia and related to JNK activation, we investigated their role in signaling this response. Whereas exogenous addition of H 2 O 2 was sufficient to activate JNK, reactive oxygen species scavengers were without effect on hypoxiainduced JNK or HIF-1 activation. Thus, hypoxia-elicited MDR1 expression, which depends on HIF-1 activation, depends at least in part on signaling via activation of JNK. Furthermore, these events are independent of the generation of reactive oxygen intermediates. Thus, JNK may represent a therapeutic target in the prevention of tumor resistance to chemotherapeutic treatment.
INTRODUCTION
Within the microenvironment of a developing tumor, decreased vascular supply and increased energy demand to maintain proliferation result in the formation of regions of hypoxia (1) . This results in the activation of a rapid and specific maladaptive molecular response, which results in the up-regulation of genes that promote tumor perfusion, survival, and growth (2) . Hypoxia-inducible factor 1 (HIF-1) is the master regulator of this adaptive response to hypoxia (3) . In normoxia, HIF-1␣ is generated at a high level and degraded in an oxygen-dependent manner (2) . During conditions of hypoxia, HIF-1␣ accumulates, dimerizes with HIF-1␤ to form HIF-1, and translocates to the nucleus where it activates the expression of an array of adaptive genes, such as vascular endothelial growth factor (2) . Genes under the regulation of HIF-1 generally support tumor survival through increased angiogenesis, vasodilation, and glycolytic capacity (2) .
A number of studies have shown a link between tumor hypoxia and chemotherapeutic resistance. Chemotherapeutic agents are broadly less effective in the induction of cell death in hypoxia in studies using drugs, including cisplatin, etoposide, bleomycin, and mitomycin C (4). Hypoxia-elicited chemotherapeutic resistance has been reported in a number of cell types, including fibroblasts, breast cancer cells, glioma cells, and testicular germ cells (4 -6) . Thus, hypoxia-associated chemotherapeutic resistance is a broad phenomenon. Among the genes increased in response to hypoxia, which may contribute to drug resistance, is the multidrug resistance (MDR1) gene, which encodes P-glycoprotein. We previously have shown that MDR1 gene expression and subsequent functional P-glycoprotein expression is dramatically up-regulated in a HIF-1-dependent manner in response to hypoxia (7) . Confirmation of this work by Wartenberg et al. (8) implicated an inverse role for reactive oxygen species (ROS) in the regulation of HIF-1 and subsequent MDR1 expression.
The c-Jun NH 2 -terminal kinase (JNK) is a member of the mitogenactivated protein kinase (MAPK) signaling cascade that typically is activated in response to cellular stress (9) . JNK activation has been observed in hypoxia associated in vivo in melanoma metastases (10) , pulmonary arterial hypertension (11), cerebral ischemia (12, 13) , and mouse embryo fibroblasts (14) , as well as in vitro in a number of cell lines (15) (16) (17) (18) . Osborn et al. (19) also have shown a link between JNK activity and MDR1 gene expression. The role of ROS production in the activation of JNK remains incompletely understood. Although it appears that JNK is sensitive to activation in response to oxidative stress, it is not clear whether this is the mechanism of induction in hypoxia. In this study, we confirm that JNK activation occurs in response to hypoxia in a time-dependent manner in vitro and in colonic mucosal tissues from mice exposed to whole animal hypoxia. Because activation of JNK through overexpression of the upstream kinase MAPK kinase kinase (MEKK-1) in normoxia is capable of mimicking hypoxia-induced HIF-1 activation and subsequent MDR1 up-regulation, we hypothesized a link between hypoxia-elicited JNK activation and increased MDR1 gene expression through HIF.
A number of studies have investigated functional interactions between increased JNK activation and increased HIF-1 activity. Indirect effects of JNK on HIF-1 have been reported through c-Jun (20) and activator protein-1 (21) . Furthermore, hypoxia-independent activation of HIF-1 in response to paracrine stimuli, including hepatocyte growth factor (22, 23) and insulin-like growth factor (21) , has been shown to involve a role for JNK. However, the role of JNK in modulating hypoxia-elicited HIF-1 stability and transactivation potential is not known. In this study, we show that hypoxia-elicited HIF-1 activity depends on the activation of JNK. Furthermore, these are pivotal signaling events in mediating the hypoxic up-regulation of drug resistance-associated genes such as MDR1. Thus, JNK activation may represent a promising therapeutic target to combat hypoxia-dependent chemotherapeutic resistance.
MATERIALS AND METHODS
Cell Culture. HeLa cells were cultured in minimum essential medium supplemented with nonessential amino acids, penicillin/streptomycin, and 10% (v/v) fetal calf serum as described previously (24) . Cells were cultured at 37°C in a humidified atmosphere under hypoxic (1% O 2 , measured cell-free medium PO 2 ϭ 15 torr) or normoxic (21% O 2 , measured cell-free medium PO 2 ϭ 136 torr) conditions with an atmospheric balance of 95%N 2 /5%CO 2 . Medium PO 2 measurements were made using an Oxylite PO 2 measurement system (Oxford Optronix, Oxford, United Kingdom).
Animal Model of Hypoxia. Mice were exposed to hypoxia (8% atmospheric oxygen) for 0 to 6 hours as described previously (25) . This protocol was in accordance with NIH guidelines for the use of live animals and was approved by the institutional animal care and use committee at Brigham and Women's Hospital (Boston, MA). Following exposure, colonic mucosal tissue was removed, dissected along the mesenteric border, washed, and snap frozen for further analysis.
Western Blot Analysis. To examine JNK activation, whole cell lysates were prepared as described previously (26) . Lysates normalized to protein levels were separated by 10% SDS-PAGE, transferred to nitrocellulose, and probed with anti-JNK (Cell Signaling Technology, Inc., Beverly, MA), antiphospho-JNK (Cell Signaling Technology, Inc.), P-glycoprotein (Calbiochem, La Jolla, CA) or anti-HIF-1␣ (Affinity BioReagents, Golden, CO) antibodies. Following washing, a species-matched, peroxidase-conjugated secondary antibody was added (Cell Signaling Technologies, Inc.). Labeled bands were detected by enhanced chemiluminescence (Bio-Rad, Hercules, CA).
Reverse-Transcription PCR. MDR1 expression was assessed by reverse transcription-PCR from cDNA prepared from total cell RNA using the following primers (Sigma Chemical Co., St. Louis, MO): MDR1 sense, 5Ј-CCCATCATTGCAATAGCAGG-3Ј and MDR1 antisense, 5Ј-GTTCAAACT-TCTGCTCCTGA-3Ј. Control primers for 18S RNA were sense, 5Ј-GTGGA-GCGATTTGTCTGGTT-3Ј and antisense, 5Ј-CGCTGAGCCAGTCAGTGT-AG-3Ј. cDNA was amplified by an initial incubation at 95°C for 5 minutes, followed by 25 (18S) or 39 (MDR1) cycles of 94°C for 30 seconds, 55°C for 30 seconds, 72°C for 60 seconds, and a final extension at 72°C for 5 minutes. PCR products were separated by electrophoresis on a 2% agarose gel.
Transfections. An HIF-1-or cyclic AMP-responsive element binding protein (CREB)-dependent luciferase reporter assay was used to investigate the impact of hypoxia or MEKK-1 overexpression on transcriptional events as described previously (27) . Furthermore, reporter genes under the control of wild-type or hypoxia-response element (HRE)-mutated MDR promoter regions were used as described previously (7). MDR promoter mutations involved a three nucleotide mutation in the HRE (7). Briefly, HeLa cells were grown to ϳ60% confluence and transfected with a luciferase reporter plasmid under the control of a basic promoter element (TATA) plus a defined inducible cis-enhancer element containing HRE or cyclic AMP response-element (CRE) motifs. Luciferase activity was measured by luminometry.
Hypoxia-Inducible Factor 1/DNA Binding. To investigate HIF-1 binding to the consensus HRE sequence, we used the TransAM HIF-1 kit according to manufacturer's instructions (Active Motif, Carlsbad, CA). Briefly, cells were exposed to various times of hypoxia or CoCl 2 (0 to 100 mol/L), and nuclear lysates were made. Lysates were put on a 96-well plate that had immobilized double-stranded DNA sequences containing the HIF-1 binding HRE. HIF-1 binding was detected using a primary mouse anti-HIF-1 antibody and a secondary horseradish peroxidase-labeled antimouse antibody.
Statistical Analysis. Statistical analysis was carried out using one-way ANOVA or either paired or unpaired Student t test with P Ͻ 0.05 for n independent samples deemed statistically significant.
RESULTS

Hypoxia Activates JNK Phosphorylation In vitro and In vivo.
HeLa cells were exposed to increasing periods of instantaneous hypoxia by exposing cells in a hypoxia chamber to preconditioned hypoxic medium for 0 to 60 minutes. Western blot analysis reveals that hypoxia causes a rapid and time-dependent increase in JNK phosphorylation, which is maximal at 30 minutes (Fig. 1A) . Similarly, in colonic mucosal tissue taken from mice exposed to whole animal hypoxia (0 to 6 hours), phospho-JNK levels increase, whereas total JNK levels remain stable (Fig. 1B) .
Role of JNK in the Activation of MDR1 Promoter Activity and P-Glycoprotein Expression. Cells transiently transfected with the MDR1 promoter linked to a luciferase reporter gene showed an increase in transcriptional activity in response to hypoxia (4.49-Ϯ 0.89-fold; P Ͻ 0.005; n ϭ 12) and MEKK-1 (4.515-Ϯ 0.08-fold; P Ͻ 0.05; n ϭ 12) overexpression. Interestingly, the combination of hypoxia and MEKK-1 was less than additive (6.714-Ϯ 1.67-fold; n ϭ 12), indicating at least some degree of commonality in the pathways activated ( Fig. 2A) . Preincubation of cells with the specific JNK inhibitor SP600125 (0 to 10 mol/L) resulted in a significant inhibition of hypoxia-elicited MDR1 promoter activity (1.47-Ϯ 0.031- Fig. 1 . Hypoxia activates JNK in vitro and in vivo. A. Confluent monolayers of HeLa cells were exposed to preconditioned hypoxic medium in a hypoxia chamber (0.5% atmospheric O 2 ) for 0 to 60 minutes. Whole cell lysates were separated by SDS-PAGE and immunoblotted for the activated form of JNK using a specific anti-phospho-JNK antibody. Hypoxia resulted in a time-dependent and transient JNK phosphorylation. B. Mice were exposed to whole animal hypoxia (8%) for 0 to 6 hours. Colonic tissue was removed, homogenized, and tissue lysates were prepared. Phospho-JNK (top) but not total JNK (bottom) was increased in a time-dependent manner in colonic tissue from mice exposed 0 to 6 hours to whole animal hypoxia. (Fig. 2B) . Importantly, JNK inhibition with SP600125 (5 mol/L) also inhibited MEKK-1-induced MDR1 activity (8.25-fold over basal increase in activity) as compared with control (19.6-fold over basal increase in activity). Western blot analysis of whole cell lysates from HeLa cells overexpressing MEKK-1 shows up-regulation of P-glycoprotein expression (Fig. 2C) . Similarly, MDR1 mRNA was increased in cells overexpressing MEKK-1 as shown by reverse transcription-PCR (Fig.  2D) .
JNK Inhibition Specifically Inhibits Hypoxia-Inducible Factor 1-Dependent Transcriptional Activity. HeLa cells transiently transfected with an HRE-dependent luciferase reporter construct showed a significant induction when exposed to hypoxia (20.43-Ϯ 3.24-fold; P Ͻ 0.05) or MEKK-1 overexpression (10.51-Ϯ 4.37-fold; P Ͻ 0.05; Fig. 3A) . In separate experiments, hypoxia-induced HRE-luciferase activity was inhibited in a dose-dependent manner by 1 mol/L and 10 mol/L SP600125 by 62% and 81%, respectively ( Fig. 3B ; P Ͻ 0.05 in each case). Pretreatment with SP600125 also significantly inhibited HRE activity induced through overexpression of MEKK-1 (data not shown). CREB-dependent transcriptional activity also is induced during exposure of cells to hypoxia, albeit to a lesser extent than HIF-1-dependent activity. CRE-dependent reporter activity was increased by 90.2% in hypoxia in a manner that was not significantly altered by SP600125 (118.7% increase over normoxia; Fig. 3C ). Furthermore, PD98059 and SB203850, which inhibit extracellular signal-regulated kinase 1/2 MAPKs and p38, respectively, were without effect on hypoxia-induced HRE-luciferase activity (Fig.  3D) . Mutation of the HRE present in the MDR1 promoter significantly attenuates MEKK-1-induced expression (Fig. 4) . Collectively, these data indicate that HIF-1-dependent MDR1 up-regulation in hypoxia specifically depends on JNK activation.
JNK Inhibition Reverses Hypoxia but not Cobalt-Induced Hypoxia-Inducible Factor 1 Transcriptional Activity. HeLa cells were transiently transfected with HRE-luciferase before exposure to CoCl 2 (0 to 100 mol/L; 24 hours). CoCl 2 caused a dose-dependent increase in HIF-1 transcriptional activity (9.90-Ϯ 5.14-fold increase for 100 mol/L), which was not significantly inhibited by the presence of SP600125 (6.7-Ϯ 3.8-fold). Hypoxia-induced HIF-1 binding to the HRE (463 Ϯ 141% increase over normoxia) is significantly inhibited by SP600125 (147 Ϯ 46% increase over normoxia; Fig. 5A ), whereas CoCl 2 -induced HIF-1 DNA binding (100 mol/L; 458 Ϯ 22% increase over normoxia) is unaltered by the presence of SP600125 (430 Ϯ 18% increase over normoxia; Fig. 5A ). Furthermore, HIF-1 stabilization induced by hypoxia is partially inhibited by the presence of SP600125 (Fig. 5B) . Collectively, these data support a role for JNK in hypoxia-dependent HIF-1 stabilization.
Antioxidants Do Not Inhibit JNK or Hypoxia-Inducible Factor Activation in Hypoxia. To investigate the possible role of ROS in mediating the effects of hypoxia on JNK activation, we investigated the impact of ROS scavengers N-acetylcysteine (NAC) and glutathione (GTH) on hypoxia-elicited JNK phosphorylation. Although hypoxia and addition of exogenous H 2 O 2 caused an increase in JNK phosphorylation, hypoxia-induced activity was unaltered in cells pretreated with the ROS scavengers NAC (5 mmol/L) or GTH (5 mmol/L; Fig. 6A ). Furthermore, NAC and GTH were without effect on hypoxia-induced HRE activity (Fig. 6B) . These data suggest that although JNK activation occurs in response to increased ROS production, this is not the signaling mechanism involved in mediating the hypoxic response.
DISCUSSION
Increased P-glycoprotein expression in hypoxia may contribute significantly to chemotherapeutic resistance in developing tumors. We have shown previously that functional up-regulation of P-glycoprotein depends on HIF-1 activation; however, the underlying molecular mechanisms remain unknown. Because hypoxia activates the stressactivated protein kinase JNK and because JNK has been associated previously with growth factor-mediated HIF-1 activation and increased expression of MDR1 (19), we investigated whether JNK has a role in hypoxia-induced HIF-1 and subsequent MDR1 activation.
Initially, we showed in vitro and in vivo that hypoxia increases JNK phosphorylation and subsequent activation. This observation is consistent with previous studies that document increased JNK activity in hypoxia (10 -18) . JNK has been implicated in hypoxia-induced apoptosis (10, 17) and ischemic brain injury (12) . Although the molecular mechanism(s) through which JNK mediates its effects in hypoxia remains to be fully elucidated, it appears that the transcription factors activator protein-1 and c-Jun are important (18) . Recent data also have implicated a positive role for nitric oxide (NO) in mediating JNK phosphorylation in hypoxia (13) . We recently have implicated NO as a pivotal regulator of the cellular hypoxic HIF-1 response through the regulation of intracellular oxygen availability (28) . Thus, hypoxiaelicited JNK activation may be under the control of endogenous levels of NO.
ROS have been implicated in the activation of JNK and MDR1 (29, 30) . Furthermore, it has been reported that mitochondrial ROS production is increased in hypoxia (31) . Thus, we investigated whether ROS were responsible for hypoxic activation of JNK. Our findings support the concept that JNK is ROS sensitive because the addition of exogenous H 2 O 2 resulted in JNK activity; however, ROS scavengers did not alter hypoxia-elicited JNK or HIF-1 activation, indicating that ROS production is not a primary signaling mechanism to JNK in hypoxia.
The mechanism by which JNK activation leads to altered HIF-1 accumulation and activity remains to be fully elucidated. Previous work has implicated a direct effect of activated JNK on HIF (22) or an indirect effect mediated through c-Jun activation. In each case, however, JNK activation correlated positively with HIF-1-dependent transcription.
Interestingly, the inhibitory effects of SP600125 were specific for hypoxia-induced HIF-1 activation and were not effective in cobaltinduced activation. It is likely that although the signaling mechanisms activated by hypoxia and cobalt result in the same endpoint (HIF-1␣ stabilization), the initial sensing mechanisms are different. Although hypoxia-induced HIF-1 activation is likely to involve a mitochondrial component (because this is the primary consumer of oxygen in the cell; ref. 32) , cobalt directly inhibits the prolyl hydroxylase enzymes that direct HIF-1␣ to degradation in the presence of oxygen (2) . Thus, it is likely that role of JNK in HIF-1 activation occurs at a site upstream of prolyl hydroxylase activity. Future work will determine whether JNK specifically alters mitochondrial oxygen consumption through the regulation of oxidative phosphorylation.
Finally, we and others have shown previously that a range of genes are under the control of the transcriptional regulator HIF-1 in response to hypoxia (24) . These genes are generally directed toward the induction of a protective or adaptive response to hypoxia and support tissue survival. In developing tumors, this may represent a maladaptive response promoting tumor vascularization and survival. Increased P-glycoprotein expression may exacerbate this phenotype through the induction of chemotherapeutic resistance. A. HeLa cells were exposed to normoxia, hypoxia, or hydrogen peroxide (H 2 O 2 ) in the absence or hypoxia in the presence of the antioxidants NAC or GTH. Cells exposed to hypoxia or H 2 O 2 (0 to 100 mol/L) showed an increased JNK phosphorylation (Lanes 2, 5, and 6) . The response to hypoxia was unaltered by the presence of NAC or GTH (5 mmol/L each; Lanes 3 and 4). B. HeLa cells were transfected with a luciferase reporter construct under the control of multiple HREs before exposure to hypoxia in the presence or absence of the antioxidants NAC or GTH. Hypoxia-elicited HRE-luciferase activity was not significantly altered in the presence of NAC or GTH (5 mmol/L; n ϭ 3; P ϭ NS). Fig. 5 . JNK inhibition inhibits hypoxia-but not cobalt-induced HIF-1 DNA binding activity. A. HeLa cells were exposed to hypoxia (24 hours) or CoCl 2 (100 mol/L; 24 hours) in the presence or absence of SP600125. Following exposure to stimuli, nuclear extracts were generated, and nuclear HIF-1/HRE binding was measured using an ELISAbased method to measure HIF-1 binding to an immobilized HRE sequence. The JNK inhibitor SP600125 reversed hypoxia-induced HIF-1 DNA binding but was without effect on cobalt-induced HIF-1 DNA binding (n ϭ 3). B. HeLa cells were exposed to hypoxia in the presence and absence of the JNK inhibitor SP600125. SP600125 inhibited HIF-1 protein accumulation in response to hypoxia as determined by SDS-PAGE (n ϭ 2). 
